⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Pomerantz LLP Alerts Shareholders to Investor Suit Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Pomerantz LLP Advises of Securities Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Shareholders of Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights Before September 14, 2026 – Contact Levi & Korsinsky
accessnewswire.com
REGN
REGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky Before September 14, 2026 to Join Class Action
accessnewswire.com
REGN
Pomerantz LLP Advises Shareholders of Class Action Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Regeneron ($REGN) Investors Notified of September 14 Court Deadline in Securities Fraud Lawsuit Over Clinical Trials Allegations
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN